URL: ", "section_type": "REF", "type": "ref", "year": "2006"}, "text": "Research fact sheet [online]", "sentences": [], "annotations": [], "relations": []}, {"offset": 38878, "infons": {"fpage": "748", "lpage": "54", "name_0": "surname:Niino;given-names:M", "name_1": "surname:Bodner;given-names:C", "name_2": "surname:Simard;given-names:M-L", "pub-id_pmid": "16634035", "section_type": "REF", "source": "Ann Neurol", "type": "ref", "volume": "59", "year": "2006"}, "text": "Natalizumab effects on immune cell responses in multiple sclerosis", "sentences": [], "annotations": [], "relations": []}, {"offset": 38945, "infons": {"name_0": "surname:O'Connor;given-names:PW", "name_1": "surname:Goodman;given-names:A", "name_2": "surname:Kappos;given-names:L", "section_type": "REF", "type": "ref", "year": "2006"}, "text": "The safety and tolerability of natalizumab: results from the safety-extension study in patients with multiple sclerosis", "sentences": [], "annotations": [], "relations": []}, {"offset": 39065, "infons": {"fpage": "2038", "lpage": "43", "name_0": "surname:O'Connor;given-names:PW", "name_1": "surname:Goodman;given-names:A", "name_2": "surname:Willmer-Hulme;given-names:AJ", "pub-id_pmid": "15184611", "section_type": "REF", "source": "Neurology", "type": "ref", "volume": "62", "year": "2004"}, "text": "Randomized multicenter trial of natalizumab in acute MS relapses.